The activin axis in liver biology and disease

Mutation Research - Reviews in Mutation Research

Volumn 613, Issue 2-3, 2006, Pages 123-137

  Rodgarkia Dara, Chantal ^a   Vejda, Susanne ^b   Erlach, Natascha ^a   Losert, Annemarie ^a   Bursch, Wilfried ^a   Berger, Walter ^a   Schulte Hermann, Rolf ^a   Grusch, Michael ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Activin; Fibrosis; Hepatocellular carcinoma; Liver growth; TGF family

Indexed keywords

ACTIVIN; ACTIVIN A; ACTIVIN RECEPTOR; ALPHA 2 MACROGLOBULIN; BINDING PROTEIN; CONNECTIVE TISSUE GROWTH FACTOR; FOLLISTATIN; FOLLISTATIN RELATED PROTEIN; GROWTH FACTOR; MYELOPID; SOMATOMEDIN BINDING PROTEIN 1;

APOPTOSIS; CELL COUNT; CELL DIVISION; CELL REGENERATION; DISULFIDE BOND; DOWN REGULATION; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HEPATITIS; HUMAN; INFLAMMATION; LIVER CARCINOGENESIS; LIVER CELL; LIVER DISEASE; LIVER FIBROSIS; LIVER REGENERATION; LIVER SINUSOID; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; STELLATE CELL; TISSUE REPAIR;

ACTIVIN RECEPTORS; ACTIVINS; ANIMALS; HOMEOSTASIS; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; LIVER FAILURE; LIVER NEOPLASMS; LIVER REGENERATION; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION;

ANIMALIA; MAMMALIA;

EID: 33751008056     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrrev.2006.07.002     Document Type: Review

References (151)

1. Ling N., Ying S.Y., Ueno N., Shimasaki S., Esch F., Hotta M., and Guillemin R. Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature 321 (1986) 779-782
2. Ling N., Ying S.Y., Ueno N., Esch F., Denoroy L., and Guillemin R. Isolation and partial characterization of a Mr 32,000 protein with inhibin activity from porcine follicular fluid. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 7217-7221
3. Robertson D.M., Foulds L.M., Leversha L., Morgan F.J., Hearn M.T., Burger H.G., Wettenhall R.E., and de Kretser D.M. Isolation of inhibin from bovine follicular fluid. Biochem. Biophys. Res. Commun. 126 (1985) 220-226
4. Miyamoto K., Hasegawa Y., Fukuda M., Nomura M., Igarashi M., Kangawa K., and Matsuo H. Isolation of porcine follicular fluid inhibin of 32k daltons. Biochem. Biophys. Res. Commun. 129 (1985) 396-403
5. Rivier J., Spiess J., McClintock R., Vaughan J., and Vale W. Purification and partial characterization of inhibin from porcine follicular fluid. Biochem. Biophys. Res. Commun. 133 (1985) 120-127
6. Mottram C., and Cramer W. On the general aspects of exposure to radium on metabolism and tumour growth in the rat and the special effects on the testis and pituitary. Quart. J. Exp. Physiol. 13 (1923) 209-229
7. McCullagh D. Dual endocrine activity of testes. Science 76 (1932) 19-22
8. Hashimoto O., Tsuchida K., Ushiro Y., Hosoi Y., Hoshi N., Sugino H., and Hasegawa Y. cDNA cloning and expression of human activin betaE subunit. Mol. Cell Endocrinol. 194 (2002) 117-122
9. Hoetten G., Neidhardt H., Schneider C., and Pohl J. Cloning of a new member of the TGF-beta family: a putative new activin beta C chain. Biochem. Biophys. Res. Commun. 206 (1995) 608-613
10. Vejda S., Cranfield M., Peter B., Mellor S.L., Groome N., Schulte-Hermann R., and Rossmanith W. Expression and dimerization of the rat activin subunits betaC and betaE: evidence for the formation of novel activin dimers. J. Mol. Endocrinol. 28 (2002) 137-148
11. O'Bryan M.K., Sebire K.L., Gerdprasert O., Hedger M.P., Hearn M.T., and de Kretser D.M. Cloning and regulation of the rat activin betaE subunit. J. Mol. Endocrinol. 24 (2000) 409-418
12. Fang J., Yin W., Smiley E., Wang S.Q., and Bonadio J. Molecular cloning of the mouse activin beta E subunit gene. Biochem. Biophys. Res. Commun. 228 (1996) 669-674
13. Oda S., Nishimatsu S., Murakami K., and Ueno N. Molecular cloning and functional analysis of a new activin beta subunit: a dorsal mesoderm-inducing activity in Xenopus. Biochem. Biophys. Res. Commun. 210 (1995) 581-588
14. Mason A.J., Hayflick J.S., Ling N., Esch F., Ueno N., Ying S.Y., Guillemin R., Niall H., and Seeburg P.H. Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-beta. Nature 318 (1985) 659-663
15. Herpin A., Lelong C., and Favrel P. Transforming growth factor-beta-related proteins: an ancestral and widespread superfamily of cytokines in metazoans. Dev. Comp. Immunol. 28 (2004) 461-485
16. Chang H., Brown C.W., and Matzuk M.M. Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr. Rev. 23 (2002) 787-823
17. Gray A.M., and Mason A.J. Requirement for activin A and transforming growth factor-beta 1 pro-regions in homodimer assembly. Science 247 (1990) 1328-1330
18. Todorovic V., Jurukovski V., Chen Y., Fontana L., Dabovic B., and Rifkin D.B. Latent TGF-beta binding proteins. Int. J. Biochem. Cell Biol. 37 (2005) 38-41
19. Grusch M., Rodgarkia-Dara C., Bursch W., and Schulte-Hermann R. Activins and the liver. In: Jakowlew S. (Ed). TGF-β Superfamily Members in Normal and Tumor Biology (2006), Humana Press
20. Tuuri T., Eramaa M., Hilden K., and Ritvos O. The tissue distribution of activin beta A- and beta B-subunit and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development. J. Clin. Endocrinol. Metab. 78 (1994) 1521-1524
21. Gold E.J., O'Bryan M.K., Mellor S.L., Cranfield M., Risbridger G.P., Groome N.P., and Fleming J.S. Cell-specific expression of betaC-activin in the rat reproductive tract, adrenal and liver. Mol. Cell Endocrinol. 222 (2004) 61-69
22. Fang J., Wang S.Q., Smiley E., and Bonadio J. Genes coding for mouse activin beta C and beta E are closely linked and exhibit a liver-specific expression pattern in adult tissues. Biochem. Biophys. Res. Commun. 231 (1997) 655-661
23. Schmitt J., Hotten G., Jenkins N.A., Gilbert D.J., Copeland N.G., Pohl J., and Schrewe H. Structure, chromosomal localization, and expression analysis of the mouse inhibin/activin beta C (Inhbc) gene. Genomics 32 (1996) 358-366
24. Welt C., Sidis Y., Keutmann H., and Schneyer A. Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp. Biol. Med. (Maywood) 227 (2002) 724-752
25. Jones K.L., de Kretser D.M., Patella S., and Phillips D.J. Activin A and follistatin in systemic inflammation. Mol. Cell Endocrinol. 225 (2004) 119-125
26. Werner S., and Alzheimer C. Roles of activin in tissue repair, fibrosis, and inflammatory disease. Cytokine Growth Factor Rev. 17 (2006) 157-171
27. Beattie G.M., Lopez A.D., Bucay N., Hinton A., Firpo M.T., King C.C., and Hayek A. Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem Cells 23 (2005) 489-495
28. McDowell N., and Gurdon J.B. Activin as a morphogen in Xenopus mesoderm induction. Semin. Cell Dev. Biol. 10 (1999) 311-317
29. Phillips D.J., Jones K.L., Clarke I.J., Scheerlinck J.P., and de Kretser D.M. Activin A: from sometime reproductive factor to genuine cytokine. Vet. Immunol. Immunopathol. 108 (2005) 23-27
30. de Kretser D.M., Hedger M.P., Loveland K.L., and Phillips D.J. Inhibins, activins and follistatin in reproduction. Hum. Reprod. Update 8 (2002) 529-541
31. Maguer-Satta V., Bartholin L., Jeanpierre S., Ffrench M., Martel S., Magaud J.P., and Rimokh R. Regulation of human erythropoiesis by activin A, BMP2, and BMP4, members of the TGFbeta family. Exp. Cell Res. 282 (2003) 110-120
32. Chen Y.G., Wang Q., Lin S.L., Chang C.D., Chung J., and Ying S.Y. Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis. Exp. Biol. Med. (Maywood) 231 (2006) 534-544
33. Matzuk M.M., Kumar T.R., Vassalli A., Bickenbach J.R., Roop D.R., Jaenisch R., and Bradley A. Functional analysis of activins during mammalian development. Nature 374 (1995) 354-356
34. Vassalli A., Matzuk M.M., Gardner H.A., Lee K.F., and Jaenisch R. Activin/inhibin beta B subunit gene disruption leads to defects in eyelid development and female reproduction. Genes Dev. 8 (1994) 414-427
35. Lau A.L., Kumar T.R., Nishimori K., Bonadio J., and Matzuk M.M. Activin betaC and betaE genes are not essential for mouse liver growth, differentiation, and regeneration. Mol. Cell Biol. 20 (2000) 6127-6137
36. Abe Y., Minegishi T., and Leung P.C. Activin receptor signaling. Growth Factors 22 (2004) 105-110
37. Attisano L., Wrana J.L., Montalvo E., and Massague J. Activation of signalling by the activin receptor complex. Mol. Cell Biol. 16 (1996) 1066-1073
38. Tsuchida K., Nakatani M., Yamakawa N., Hashimoto O., Hasegawa Y., and Sugino H. Activin isoforms signal through type I receptor serine/threonine kinase ALK7. Mol. Cell Endocrinol. 220 (2004) 59-65
39. Wada W., Maeshima A., Zhang Y.Q., Hasegawa Y., Kuwano H., and Kojima I. Assessment of the function of the betaC-subunit of activin in cultured hepatocytes. Am. J. Physiol. Endocrinol. Metab. 287 (2004) E247-E254
40. Muenster U., Harrison C.A., Donaldson C., Vale W., and Fischer W.H. An activin-A/C chimera exhibits activin and myostatin antagonistic properties. J. Biol. Chem. 280 (2005) 36626-36632
41. Cook R.W., Thompson T.B., Jardetzky T.S., and Woodruff T.K. Molecular biology of inhibin action. Semin. Reprod. Med. 22 (2004) 269-276
42. Lewis K.A., Gray P.C., Blount A.L., MacConell L.A., Wiater E., Bilezikjian L.M., and Vale W. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 404 (2000) 411-414
43. Heldin C.H., Miyazono K., and ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390 (1997) 465-471
44. Kanamaru C., Yasuda H., and Fujita T. Involvement of Smad proteins in TGF-beta and activin A-induced apoptosis and growth inhibition of liver cells. Hepatol. Res. 23 (2002) 211-219
45. Chen W., Woodruff T.K., and Mayo K.E. Activin A-induced HepG2 liver cell apoptosis: involvement of activin receptors and smad proteins. Endocrinology 141 (2000) 1263-1272
46. Valderrama-Carvajal H., Cocolakis E., Lacerte A., Lee E.H., Krystal G., Ali S., and Lebrun J.J. Activin/TGF-beta induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP. Nat. Cell Biol. 4 (2002) 963-969
47. Zhang L., Deng M., Parthasarathy R., Wang L., Mongan M., Molkentin J.D., Zheng Y., and Xia Y. MEKK1 transduces activin signals in keratinocytes to induce actin stress fiber formation and migration. Mol. Cell Biol. 25 (2005) 60-65
48. Tanimoto K., Yoshida E., Mita S., Nibu Y., Murakami K., and Fukamizu A. Human activin betaA gene. Identification of novel 5′ exon, functional promoter, and enhancers. J. Biol. Chem. 271 (1996) 32760-32769
49. Niimi S., Horikawa M., Seki T., Ariga T., Kobayashi T., and Hayakawa T. Effect of activins AB and B on DNA synthesis stimulated by epidermal growth factor in primary cultured rat hepatocytes. Biol. Pharm. Bull. 25 (2002) 437-440
50. Mellor S.L., Ball E.M., O'Connor A.E., Ethier J.F., Cranfield M., Schmitt J.F., Phillips D.J., Groome N.P., and Risbridger G.P. Activin betaC-subunit heterodimers provide a new mechanism of regulating activin levels in the prostate. Endocrinology 144 (2003) 4410-4419
51. Xu J., McKeehan K., Matsuzaki K., and McKeehan W.L. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism. J. Biol. Chem. 270 (1995) 6308-6313
52. Y. Ushiro, O. Hashimoto, M. Seki, A. Hachiya, H. Shoji, Y. Hasegawa, Analysis of the function of activin beta(C) subunit using recombinant protein, J Reprod Dev, Epub ahead of print (2006).
53. Ueno N., Ling N., Ying S.Y., Esch F., Shimasaki S., and Guillemin R. Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 8282-8286
54. Michel U., Rao A., and Findlay J.K. Rat follistatin: ontogeny of steady-state mRNA levels in different tissues predicts organ-specific functions. Biochem. Biophys. Res. Commun. 180 (1991) 223-230
55. Sugino K., Kurosawa N., Nakamura T., Takio K., Shimasaki S., Ling N., Titani K., and Sugino H. Molecular heterogeneity of follistatin, an activin-binding protein. Higher affinity of the carboxyl-terminal truncated forms for heparan sulfate proteoglycans on the ovarian granulosa cell. J. Biol. Chem. 268 (1993) 15579-15587
56. Schneyer A.L., Rzucidlo D.A., Sluss P.M., and Crowley Jr. W.F. Characterization of unique binding kinetics of follistatin and activin or inhibin in serum. Endocrinology 135 (1994) 667-674
57. Harrington A.E., Morris-Triggs S.A., Ruotolo B.T., Robinson C.V., Ohnuma S., and Hyvonen M. Structural basis for the inhibition of activin signalling by follistatin. EMBO J. 25 (2006) 1035-1045
58. de Winter J.P., ten Dijke P., de Vries C.J., van Achterberg T.A., Sugino H., de Waele P., Huylebroeck D., Verschueren K., and van den Eijnden-van Raaij A.J. Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors. Mol. Cell Endocrinol. 116 (1996) 105-114
59. Shimasaki S., Koga M., Esch F., Cooksey K., Mercado M., Koba A., Ueno N., Ying S.Y., Ling N., and Guillemin R. Primary structure of the human follistatin precursor and its genomic organization. Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 4218-4222
60. Keutmann H.T., Schneyer A.L., and Sidis Y. The role of follistatin domains in follistatin biological action. Mol. Endocrinol. 18 (2004) 228-240
61. Nakamura T., Sugino K., Titani K., and Sugino H. Follistatin, an activin-binding protein, associates with heparan sulfate chains of proteoglycans on follicular granulosa cells. J. Biol. Chem. 266 (1991) 19432-19437
62. Hashimoto O., Nakamura T., Shoji H., Shimasaki S., Hayashi Y., and Sugino H. A novel role of follistatin, an activin-binding protein, in the inhibition of activin action in rat pituitary cells. Endocytotic degradation of activin and its acceleration by follistatin associated with cell-surface heparan sulfate. J. Biol. Chem. 272 (1997) 13835-13842
63. Schneyer A., Schoen A., Quigg A., and Sidis Y. Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG). Endocrinology 144 (2003) 1671-1674
64. Iemura S., Yamamoto T.S., Takagi C., Uchiyama H., Natsume T., Shimasaki S., Sugino H., and Ueno N. Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 9337-9342
65. Amthor H., Nicholas G., McKinnell I., Kemp C.F., Sharma M., Kambadur R., and Patel K. Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. Dev. Biol. 270 (2004) 19-30
66. Glister C., Kemp C.F., and Knight P.G. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin. Reproduction 127 (2004) 239-254
67. Ullman C.G., and Perkins S.J. The Factor I and follistatin domain families: the return of a prodigal son. Biochem. J. 326 Pt 3 (1997) 939-941
68. Tsuchida K., Arai K.Y., Kuramoto Y., Yamakawa N., Hasegawa Y., and Sugino H. Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-beta family. J. Biol. Chem. 275 (2000) 40788-40796
69. Hayette S., Gadoux M., Martel S., Bertrand S., Tigaud I., Magaud J.P., and Rimokh R. FLRG (follistatin-related gene), a new target of chromosomal rearrangement in malignant blood disorders. Oncogene 16 (1998) 2949-2954
70. Tortoriello D.V., Sidis Y., Holtzman D.A., Holmes W.E., and Schneyer A.L. Human follistatin-related protein: a structural homologue of follistatin with nuclear localization. Endocrinology 142 (2001) 3426-3434
71. Saito S., Sidis Y., Mukherjee A., Xia Y., and Schneyer A. Differential biosynthesis and intracellular transport of follistatin isoforms and follistatin-like-3. Endocrinology 146 (2005) 5052-5062
72. Bartholin L., Maguer-Satta V., Hayette S., Martel S., Gadoux M., Corbo L., Magaud J.P., and Rimokh R. Transcription activation of FLRG and follistatin by activin A, through Smad proteins, participates in a negative feedback loop to modulate activin A function. Oncogene 21 (2002) 2227-2235
73. Chu C.T., and Pizzo S.V. Alpha 2-macroglobulin, complement, and biologic defense: antigens, growth factors, microbial proteases, and receptor ligation. Lab. Invest. 71 (1994) 792-812
74. Mather J.P. Follistatins and alpha 2-macroglobulin are soluble binding proteins for inhibin and activin. Horm. Res. 45 (1996) 207-210
75. Phillips D.J., McFarlane J.R., Hearn M.T., and de Kretser D.M. Inhibin, activin and follistatin bind preferentially to the transformed species of alpha 2-macroglobulin. J. Endocrinol. 155 (1997) 65-71
76. Hwa V., Oh Y., and Rosenfeld R.G. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr. Rev. 20 (1999) 761-787
77. Komatsu S., Okazaki Y., Tateno M., Kawai J., Konno H., Kusakabe M., Yoshiki A., Muramatsu M., Held W.A., and Hayashizaki Y. Methylation and downregulated expression of mac25/insulin-like growth factor binding protein-7 is associated with liver tumorigenesis in SV40T/t antigen transgenic mice, screened by restriction landmark genomic scanning for methylation (RLGS-M). Biochem. Biophys. Res. Commun. 267 (2000) 109-117
78. Kato M.V., Sato H., Tsukada T., Ikawa Y., Aizawa S., and Nagayoshi M. A follistatin-like gene, mac25, may act as a growth suppressor of osteosarcoma cells. Oncogene 12 (1996) 1361-1364
79. Kato M.V. A secreted tumor-suppressor, mac25, with activin-binding activity. Mol. Med. 6 (2000) 126-135
80. Gold E.J., Zhang X., Wheatley A.M., Mellor S.L., Cranfield M., Risbridger G.P., Groome N.P., and Fleming J.S. BetaA- and betaC-activin, follistatin, activin receptor mRNA and betaC-activin peptide expression during rat liver regeneration. J. Mol. Endocrinol. 34 (2005) 505-515
81. Adamson E.D., Minchiotti G., and Salomon D.S. Cripto: a tumor growth factor and more. J. Cell. Physiol. 190 (2002) 267-278
82. Adkins H.B., Bianco C., Schiffer S.G., Rayhorn P., Zafari M., Cheung A.E., Orozco O., Olson D., De Luca A., Chen L.L., Miatkowski K., Benjamin C., Normanno N., Williams K.P., Jarpe M., LePage D., Salomon D., and Sanicola M. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. J. Clin. Invest. 112 (2003) 575-587
83. Gray P.C., Harrison C.A., and Vale W. Cripto forms a complex with activin and type II activin receptors and can block activin signaling. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 5193-5198
84. Onichtchouk D., Chen Y.G., Dosch R., Gawantka V., Delius H., Massague J., and Niehrs C. Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature 401 (1999) 480-485
85. Shoji H., Tsuchida K., Kishi H., Yamakawa N., Matsuzaki T., Liu Z., Nakamura T., and Sugino H. Identification and characterization of a PDZ protein that interacts with activin type II receptors. J. Biol. Chem. 275 (2000) 5485-5492
86. Matsuzaki T., Hanai S., Kishi H., Liu Z., Bao Y., Kikuchi A., Tsuchida K., and Sugino H. Regulation of endocytosis of activin type II receptors by a novel PDZ protein through Ral/Ral-binding protein 1-dependent pathway. J. Biol. Chem. 277 (2002) 19008-19018
87. Liu Z.H., Tsuchida K., Matsuzaki T., Bao Y.L., Kurisaki A., and Sugino H. Characterization of isoforms of activin receptor-interacting protein 2 that augment activin signaling. J. Endocrinol. 189 (2006) 409-421
88. Taub R. Liver regeneration: from myth to mechanism. Nat. Rev. Mol. Cell Biol. 5 (2004) 836-847
89. Hully J.R., Chang L., Schwall R.H., Widmer H.R., Terrell T.G., and Gillett N.A. Induction of apoptosis in the murine liver with recombinant human activin A. Hepatology 20 (1994) 854-862
90. Schwall R.H., Robbins K., Jardieu P., Chang L., Lai C., and Terrell T.G. Activin induces cell death in hepatocytes in vivo and in vitro. Hepatology 18 (1993) 347-356
91. Yasuda H., Mine T., Shibata H., Eto Y., Hasegawa Y., Takeuchi T., Asano S., and Kojima I. Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. J. Clin. Invest. 92 (1993) 1491-1496
92. Takabe K., Lebrun J.J., Nagashima Y., Ichikawa Y., Mitsuhashi M., Momiyama N., Ishikawa T., Shimada H., and Vale W.W. Interruption of activin A autocrine regulation by antisense oligodeoxynucleotides accelerates liver tumor cell proliferation. Endocrinology 140 (1999) 3125-3132
93. Matzuk M.M., Finegold M.J., Mather J.P., Krummen L., Lu H., and Bradley A. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8817-8821
94. Kogure K., Zhang Y.Q., Maeshima A., Suzuki K., Kuwano H., and Kojima I. The role of activin and transforming growth factor-beta in the regulation of organ mass in the rat liver. Hepatology 31 (2000) 916-921
95. Takabe K., Wang L., Leal A.M., Macconell L.A., Wiater E., Tomiya T., Ohno A., Verma I.M., and Vale W. Adenovirus-mediated overexpression of follistatin enlarges intact liver of adult rats. Hepatology 38 (2003) 1107-1115
96. Ichikawa T., Zhang Y.Q., Kogure K., Hasegawa Y., Takagi H., Mori M., and Kojima I. Transforming growth factor beta and activin tonically inhibit DNA synthesis in the rat liver. Hepatology 34 (2001) 918-925
97. Takamura K., Tsuchida K., Miyake H., Tashiro S., and Sugino H. Activin and activin receptor expression changes in liver regeneration in rat. J. Surg. Res. 126 (2005) 3-11
98. Date M., Matsuzaki K., Matsushita M., Tahashi Y., Sakitani K., and Inoue K. Differential regulation of activin A for hepatocyte growth and fibronectin synthesis in rat liver injury. J. Hepatol. 32 (2000) 251-260
99. Zhang Y.Q., Shibata H., Schrewe H., and Kojima I. Reciprocal expression of mRNA for inhibin betaC and betaA subunits in hepatocytes. Endocr. J. 44 (1997) 759-764
100. Oe S., Lemmer E.R., Conner E.A., Factor V.M., Leveen P., Larsson J., Karlsson S., and Thorgeirsson S.S. Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice. Hepatology 40 (2004) 1098-1105
101. Wada W., Kuwano H., Hasegawa Y., and Kojima I. The dependence of transforming growth factor-beta-induced collagen production on autocrine factor activin A in hepatic stellate cells. Endocrinology 145 (2004) 2753-2759
102. Endo D., Kogure K., Hasegawa Y., Maku-uchi M., and Kojima I. Activin A augments vascular endothelial growth factor activity in promoting branching tubulogenesis in hepatic sinusoidal endothelial cells. J. Hepatol. 40 (2004) 399-404
103. Kogure K., Omata W., Kanzaki M., Zhang Y.Q., Yasuda H., Mine T., and Kojima I. A single intraportal administration of follistatin accelerates liver regeneration in partially hepatectomized rats. Gastroenterology 108 (1995) 1136-1142
104. Kogure K., Zhang Y.Q., Shibata H., and Kojima I. Immediate onset of DNA synthesis in remnant rat liver after 90% hepatectomy by an administration of follistatin. J. Hepatol. 29 (1998) 977-984
105. Endo D., Maku-Uchi M., and Kojima I. Activin or follistatin: which is more beneficial to support liver regeneration after massive hepatectomy?. Endocr. J. 53 (2006) 73-78
106. Kim B.C., van Gelder H., Kim T.A., Lee H.J., Baik K.G., Chun H.H., Lee D.A., Choi K.S., and Kim S.J. Activin receptor-like kinase-7 induces apoptosis through activation of MAPKs in a Smad3-dependent mechanism in hepatoma cells. J. Biol. Chem. 279 (2004) 28458-28465
107. Butler C.M., Gold E.J., and Risbridger G.P. Should activin betaC be more than a fading snapshot in the activin/TGFbeta family album?. Cytokine Growth Factor Rev. 16 (2005) 377-385
108. Vejda S., Erlach N., Peter B., Drucker C., Rossmanith W., Pohl J., Schulte-Hermann R., and Grusch M. Expression of activins C and E induces apoptosis in human and rat hepatoma cells. Carcinogenesis 24 (2003) 1801-1809
109. Chabicovsky M., Herkner K., and Rossmanith W. Overexpression of activin beta(C) or activin beta(E) in the mouse liver inhibits regenerative deoxyribonucleic acid synthesis of hepatic cells. Endocrinology 144 (2003) 3497-3504
110. Wada W., Medina J., Hasegawa Y., Kuwano H., and Kojima I. Adenovirus-mediated overexpression of the activin betaC subunit accelerates liver regeneration in partially hepatectomized rats. J. Hepatol. 43 (2005) 823-828
111. Esquela A.F., Zimmers T.A., Koniaris L.G., Sitzmann J.V., and Lee S.J. Transient down-regulation of inhibin-betaC expression following partial hepatectomy. Biochem. Biophys. Res. Commun. 235 (1997) 553-556
112. Wada W., Medina J.J., Kuwano H., and Kojima I. Comparison of the function of the beta(C) and beta(E) subunits of activin in AML12 hepatocytes. Endocr. J. 52 (2005) 169-175
113. Hashimoto O., Ushiro Y., Sekiyama K., Yamaguchi O., Yoshioka K., Mutoh K., and Hasegawa Y. Impaired growth of pancreatic exocrine cells in transgenic mice expressing human activin betaE subunit. Biochem. Biophys. Res. Commun. 341 (2006) 416-424
114. Schulte-Hermann R. Two-stage control of cell proliferation induced in rat liver by alpha-hexachlorocyclohexane. Cancer Res. 37 (1977) 166-171
115. N. Erlach, C. Drucker, O. Teufelhofer, S. Vejda, B. Grasl-Kraupp, J. Pohl, R. Schulte-Hermann, M. Grusch, C. Gerner, Activin C has anti-inflammatory properties in rat hepatocytes, in preparation.
116. De Bleser P.J., Niki T., Xu G., Rogiers V., and Geerts A. Localization and cellular sources of activins in normal and fibrotic rat liver. Hepatology 26 (1997) 905-912
117. Gold E.J., Francis R.J., Zimmermann A., Mellor S.L., Cranfield M., Risbridger G.P., Groome N.P., Wheatley A.M., and Fleming J.S. Changes in activin and activin receptor subunit expression in rat liver during the development of CCl4-induced cirrhosis. Mol. Cell Endocrinol. 201 (2003) 143-153
118. Huang X., Li D.G., Wang Z.R., Wei H.S., Cheng J.L., Zhan Y.T., Zhou X., Xu Q.F., Li X., and Lu H.M. Expression changes of activin A in the development of hepatic fibrosis. World J. Gastroenterol. 7 (2001) 37-41
119. Huang X., Li D., Lu H., Wang Z., Wei H., Wang Y., Zhang J., and Xu Q. Expression of activins, follistatin mRNA in the development of hepatic fibrosis. Zhonghua Gan Zang Bing Za Zhi 10 (2002) 85-88
120. Sugiyama M., Ichida T., Sato T., Ishikawa T., Matsuda Y., and Asakura H. Expression of activin A is increased in cirrhotic and fibrotic rat livers. Gastroenterology 114 (1998) 550-558
121. Nusing R.M., and Barsig J. Induction of prostanoid, nitric oxide, and cytokine formation in rat bone marrow derived macrophages by activin A. Br. J. Pharmacol. 127 (1999) 919-926
122. Zhang X.J., Li Y., Tai G.X., Xu G.Y., Zhang P.Y., Yang Y., Lao F.X., and Liu Z.H. Effects of activin A on the activities of the mouse peritoneal macrophages. Cell Mol. Immunol. 2 (2005) 63-67
123. Patella S., Phillips D.J., Tchongue J., de Kretser D.M., and Sievert W. Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis. Am. J. Physiol. Gastrointest. Liver Physiol. 290 (2006) G137-G144
124. Patella S., Phillips D.J., de Kretser D.M., Evans L.W., Groome N.P., and Sievert W. Characterization of serum activin-A and follistatin and their relation to virological and histological determinants in chronic viral hepatitis. J. Hepatol. 34 (2001) 576-583
125. Yuen M.F., Norris S., Evans L.W., Langley P.G., and Hughes R.D. Transforming growth factor-beta 1, activin and follistatin in patients with hepatocellular carcinoma and patients with alcoholic cirrhosis. Scand. J. Gastroenterol. 37 (2002) 233-238
126. Elsammak, M.Y., Amin, G.M., Khalil, G.M., Ragab, W.S., Abaza, M.M., 2006. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis. Clin. Biochem.
127. Lee D.K., Park S.H., Yi Y., Choi S.G., Lee C., Parks W.T., Cho H., de Caestecker M.P., Shaul Y., Roberts A.B., and Kim S.J. The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis. Genes Dev. 15 (2001) 455-466
128. Palmes D., Skawran S., and Spiegel H.U. Acute liver failure: from bench to bedside. Transplant Proc. 37 (2005) 1628-1631
129. O'Grady J.G. Acute liver failure. Postgrad. Med. J. 81 (2005) 148-154
130. Hughes R.D., and Evans L.W. Activin A and follistatin in acute liver failure. Eur. J. Gastroenterol. Hepatol. 15 (2003) 127-131
131. Lin S.D., Kawakami T., Ushio A., Sato A., Sato S., Iwai M., Endo R., Takikawa Y., and Suzuki K. Ratio of circulating follistatin and activin A reflects the severity of acute liver injury and prognosis in patients with acute liver failure. J. Gastroenterol. Hepatol. 21 (2006) 374-380
132. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
133. Risbridger G.P., Schmitt J.F., and Robertson D.M. Activins and inhibins in endocrine and other tumors. Endocr. Rev. 22 (2001) 836-858
134. Pirisi M., Fabris C., Luisi S., Santuz M., Toniutto P., Vitulli D., Federico E., Del Forno M., Mattiuzzo M., Branca B., and Petraglia F. Evaluation of circulating activin-A as a serum marker of hepatocellular carcinoma. Cancer Detect. Prev. 24 (2000) 150-155
135. Mashima H., Kanzaki M., Nobusawa R., Zhang Y.Q., Suzuki M., Mine T., and Kojima I. Derangements in the activin-follistatin system in hepatoma cells. Gastroenterology 108 (1995) 834-840
136. Rossmanith W., Chabicovsky M., Grasl-Kraupp B., Peter B., Schausberger E., and Schulte-Hermann R. Follistatin overexpression in rodent liver tumors: a possible mechanism to overcome activin growth control. Mol. Carcinogen. 35 (2002) 1-5
137. M. Grusch, C. Drucker, B. Peter-Vörösmary, N. Erlach, A. Losert, W. Schneider, M. Hermann, N. Groome, W. Parzefall, B. Grasl-Kraupp, R. Schulte-Hermann, Deregulation of the activin-follistatin system in hepatocarcinogenesis, J. Hepatol., 2006, doi:10.1016/j.jhep.2006.06.014.
138. Fuwii M., Ishikawa M., Iuchi M., and Tashiro S. Effect of follistatin on rat liver regeneration and tumor growth after portal occlusion. Hepatogastroenterology 52 (2005) 833-838
139. Yakicier M.C., Irmak M.B., Romano A., Kew M., and Ozturk M. Smad2 and Smad4 gene mutations in hepatocellular carcinoma. Oncogene 18 (1999) 4879-4883
140. Hempen P.M., Zhang L., Bansal R.K., Iacobuzio-Donahue C.A., Murphy K.M., Maitra A., Vogelstein B., Whitehead R.H., Markowitz S.D., Willson J.K., Yeo C.J., Hruban R.H., and Kern S.E. Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers. Cancer Res. 63 (2003) 994-999
141. Su G.H., Bansal R., Murphy K.M., Montgomery E., Yeo C.J., Hruban R.H., and Kern S.E. ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 3254-3257
142. Wagner K., Peters M., Scholz A., Benckert C., Ruderisch H.S., Wiedenmann B., and Rosewicz S. Activin A stimulates vascular endothelial growth factor gene transcription in human hepatocellular carcinoma cells. Gastroenterology 126 (2004) 1828-1843
143. Ling N., Ying S.Y., Ueno N., Shimasaki S., Esch F., Hotta M., and Guillemin R. A homodimer of the beta-subunits of inhibin A stimulates the secretion of pituitary follicle stimulating hormone. Biochem. Biophys. Res. Commun. 138 (1986) 1129-1137
144. Vale W., Rivier J., Vaughan J., McClintock R., Corrigan A., Woo W., Karr D., and Spiess J. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 321 (1986) 776-779
145. Attisano L., Wrana J.L., Cheifetz S., and Massague J. Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors. Cell 68 (1992) 97-108
146. Mathews L.S., and Vale W.W. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 65 (1991) 973-982
147. ten Dijke P., Yamashita H., Ichijo H., Franzen P., Laiho M., Miyazono K., and Heldin C.H. Characterization of type I receptors for transforming growth factor-beta and activin. Science 264 (1994) 101-104
148. Nakamura T., Asashima M., Eto Y., Takio K., Uchiyama H., Moriya N., Ariizumi T., Yashiro T., Sugino K., Titani K., et al. Isolation and characterization of native activin B. J. Biol. Chem. 267 (1992) 16385-16389
149. Nakamura T., Sugino K., Kurosawa N., Sawai M., Takio K., Eto Y., Iwashita S., Muramatsu M., Titani K., and Sugino H. Isolation and characterization of activin receptor from mouse embryonal carcinoma cells. Identification of its serine/threonine/tyrosine protein kinase activity. J. Biol. Chem. 267 (1992) 18924-18928
150. Mellor S.L., Cranfield M., Ries R., Pedersen J., Cancilla B., de Kretser D., Groome N.P., Mason A.J., and Risbridger G.P. Localization of activin beta(A)-, beta(B)-, and beta(C)-subunits in humanprostate and evidence for formation of new activin heterodimers of beta(C)-subunit. J. Clin. Endocrinol. Metab. 85 (2000) 4851-4858
151. Chapman S.C., Bernard D.J., Jelen J., and Woodruff T.K. Properties of inhibin binding to betaglycan, InhBP/p120 and the activin type II receptors. Mol. Cell Endocrinol. 196 (2002) 79-93